1. Home
  2. APRE vs MSS Comparison

APRE vs MSS Comparison

Compare APRE & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • MSS
  • Stock Information
  • Founded
  • APRE 2006
  • MSS 2019
  • Country
  • APRE United States
  • MSS United States
  • Employees
  • APRE N/A
  • MSS N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • MSS
  • Sector
  • APRE Health Care
  • MSS
  • Exchange
  • APRE Nasdaq
  • MSS Nasdaq
  • Market Cap
  • APRE 21.2M
  • MSS 23.2M
  • IPO Year
  • APRE 2019
  • MSS 2023
  • Fundamental
  • Price
  • APRE $2.62
  • MSS $1.28
  • Analyst Decision
  • APRE Strong Buy
  • MSS
  • Analyst Count
  • APRE 2
  • MSS 0
  • Target Price
  • APRE $15.50
  • MSS N/A
  • AVG Volume (30 Days)
  • APRE 35.9K
  • MSS 66.6K
  • Earning Date
  • APRE 03-25-2025
  • MSS 03-17-2025
  • Dividend Yield
  • APRE N/A
  • MSS N/A
  • EPS Growth
  • APRE N/A
  • MSS N/A
  • EPS
  • APRE N/A
  • MSS N/A
  • Revenue
  • APRE $1,310,839.00
  • MSS $91,193,946.00
  • Revenue This Year
  • APRE $134.21
  • MSS N/A
  • Revenue Next Year
  • APRE N/A
  • MSS N/A
  • P/E Ratio
  • APRE N/A
  • MSS N/A
  • Revenue Growth
  • APRE 130.31
  • MSS 59.04
  • 52 Week Low
  • APRE $2.15
  • MSS $0.60
  • 52 Week High
  • APRE $8.85
  • MSS $2.08
  • Technical
  • Relative Strength Index (RSI)
  • APRE 30.05
  • MSS 56.77
  • Support Level
  • APRE $2.59
  • MSS $1.23
  • Resistance Level
  • APRE $3.72
  • MSS $1.38
  • Average True Range (ATR)
  • APRE 0.35
  • MSS 0.11
  • MACD
  • APRE -0.13
  • MSS 0.01
  • Stochastic Oscillator
  • APRE 1.41
  • MSS 72.83

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: